The SEPSIS Act would direct the Secretary of Health and Human Services, acting through the CDC, to maintain a federal sepsis team focused on reducing sepsis rates nationwide. The team would lead an education campaign on hospital best practices, improve pediatric sepsis data collection, share information with CMS on sepsis quality measures, update interoperability data elements, coordinate HHS efforts on outcome measures, and carry out other sepsis-related activities as appropriate.
The bill also requires a report to Congress within one year on the development and implementation of adult and pediatric sepsis outcome measures, taking into account social and clinical risk factors. In addition, it mandates annual briefings to Congress on hospital adoption of sepsis best practices, pediatric sepsis trends, interagency coordination, data sharing, and the latest sepsis datasets. The Secretary may also create a voluntary honor roll program to recognize hospitals that maintain or improve effective sepsis programs, with public benchmarks for selection. The bill authorizes $20 million annually for fiscal years 2026 through 2030.
The bill would amend Title III of the Public Health Service Act by adding a new section on sepsis programs, creating a formal federal role for CDC-led coordination, data collection, education, and reporting on sepsis. It would affect hospitals, federal health agencies such as CDC, CMS, AHRQ, and the Office of the National Coordinator for Health Information Technology, and could influence hospital quality measurement and reporting practices. The measure does not impose a mandatory hospital program, but it could shape standards and incentives through guidance, data infrastructure, and voluntary recognition.
The bill appears broadly supportive and bipartisan in tone, with sponsors from both parties and a public-health framing centered on preventable deaths, especially among children. The findings emphasize the scale of the problem, the preventability of many deaths, and the value of existing New York hospital protocols as a model for national action. No committee debate or votes are provided, so there is no recorded opposition in the supplied materials.
The main policy questions raised by the bill are how far federal involvement should go in hospital sepsis practices, how outcome measures should account for social and clinical risk factors, and what data hospitals would be expected to report. Another potential point of discussion is whether the voluntary honor roll and reporting framework will be sufficient to drive change without mandatory standards. The bill’s emphasis on pediatric sepsis, interoperability, and cross-agency data sharing suggests likely interest from hospitals, public health officials, and health IT stakeholders, though no specific objections are included in the record provided.